NCT00001728View on ClinicalTrials.gov

Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 24, 1998

Primary Completion Date

August 19, 2007

Study Completion Date

May 2, 2011

Conditions
Polyostotic Fibrous Dysplasia
Interventions
DRUG

Fosamax (Alendronate)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00001728 - Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome | Biotech Hunter | Biotech Hunter